1. Introduction
===============

Root of *Panax notoginseng* (Burk.) F.H. Chen, also called Sanqi or Sanchi, is a highly valued Chinese medicinal herb. It has been used as a tonic and haemostatic in China for more than 400 years \[[@B1-molecules-17-05836]\]. Modern pharmacological studies have revealed that *P. notoginseng* and its components exert various effects on immune system, cardiocerebral vascular system, central nervous system, endocrine system and inflammation, *etc.* \[[@B2-molecules-17-05836],[@B3-molecules-17-05836],[@B4-molecules-17-05836]\]. Drammarane triterpenoid saponins with 20(*S*)-protopanaxatriol and 20(*S*)-protopanaxadiol aglycons have been considered the main active components of *P. notoginseng* \[[@B2-molecules-17-05836],[@B5-molecules-17-05836]\]. Actually, the biological activities of saponins were related with their structures \[[@B6-molecules-17-05836],[@B7-molecules-17-05836]\], ginsenoside Rg~1~, which has a protopanaxatriol moiety, and ginsenoside Rb~1~ with protopanaxadiol as aglycon, exhibited opposite pharmacological activity \[[@B6-molecules-17-05836]\]. In our previous study \[[@B8-molecules-17-05836]\], the chemical characteristics of different parts of *P. notoginseng* determined using HPLC-ELSD was described, and the results showed that the content and type of investigated saponins in different parts of *P. notoginseng* were distinctly diverse. Furthermore, due to detector limitations, many peaks in their profiles remained unknown. Therefore, further chemical investigation of different parts of *P. notoginseng* is necessary and very important for ensuring the safety, efficacy and their quality.

Several methods, including HPTLC \[[@B9-molecules-17-05836]\], HPLC-UV \[[@B8-molecules-17-05836]\], HPLC-ELSD \[[@B8-molecules-17-05836],[@B10-molecules-17-05836],[@B11-molecules-17-05836]\], and UPLC-UV \[[@B12-molecules-17-05836]\], have been developed by our lab for simultaneous determination of various saponins in the root of *P. notoginseng*. However, these methods suffer from insufficient sensitivity and poor identification capability for unknown peaks. Chromatography coupled with mass spectrometry is a powerful analytical tool for fast structural elucidation of complex mixtures. LC-MS has been applied to identify saponins in the roots of *P. notoginseng* \[[@B13-molecules-17-05836],[@B14-molecules-17-05836],[@B15-molecules-17-05836],[@B16-molecules-17-05836]\], *P. ginseng* \[[@B17-molecules-17-05836],[@B18-molecules-17-05836],[@B19-molecules-17-05836]\] and *P. quinquefolium* \[[@B20-molecules-17-05836],[@B21-molecules-17-05836],[@B22-molecules-17-05836]\]. However, to date, the systematic HPLC-MS study of different parts of *P. notoginseng* has not been addressed.

In the present study, a PLE and HPLC-ESI-MS/MS method was developed for separation and identification of saponins in different parts of *P. notogin*seng, including rhizome, root, fibre root, seed, stem, leaf and flower. Structural information of saponins was obtained by collision-induced dissociation (CID). Using the developed method, 41 saponins ([Figure 1](#molecules-17-05836-f001){ref-type="fig"}) were identified in different parts of *P. notoginseng* according to their fragmentation patterns and literatures; among them, 21 saponins were confirmed by comparing their retention times and ESI-MS data with those of standard compounds. Furthermore, the chemical characteristics of different parts of *P. notoginseng* were further compared.

2. Results and Discussion
=========================

2.1. Optimization of HPLC-ESI-MS/MS Conditions
----------------------------------------------

Optimization of MS parameters is a necessary step to achieve maximum signal for the protonated molecular ions. In general, ion sensitivity for the ginsenosides in negative ion mode is greater than that in positive ion mode \[[@B17-molecules-17-05836],[@B23-molecules-17-05836]\]. Our preliminary trials also confirmed that negative ion mode was more sensitive, and provided straightforward structural information about the saponins. The optimal range of capillary voltage is usually 2.0--3.5 kV for the negative ion study \[[@B24-molecules-17-05836]\], and a capillary voltage of 3.0 kV was employed in this study. Eight mM aqueous ammonium acetate was used as mobile phase additive to improve analyte ionization prior to the HPLC-MS interface. However, the baseline drifted greatly at 203 nm using its gradient elution program. Therefore, water, instead of ammonium acetate solution, was used for HPLC-UV analysis. The other ESI-MS/MS parameters, including fragment amplification, compound stability, dry gas flow, dry temperature and nebulizer gas pressure, were optimized manually to obtain the maximum signal with chemical standards of ginsenosides Rb~1~ and Rg~1~, two main ingredients in the root of *P. notoginseng*, using a syringe pump (KD Scientific Model 100, Holliston, MA, USA) connected directly with the mass spectrometer.

![Chemical structures and molecular weight of saponins identified in different parts of *P. notoginseng*. Glc, β-D-glucopyranosyl; Rha, α-L-rhamnopyranosyl; Arap, α-L-arabinopyranosyl; Araf, α-L-arabinofuranosyl; Xyl, β-D-xylopyranosyl; Glc\*, α-D-glucopyranosyl; M.W., molecular weight.](molecules-17-05836-g001){#molecules-17-05836-f001}

2.2. HPLC-UV-MS Analysis of Reference Compounds
-----------------------------------------------

Under the optimized conditions, 21 reference compounds were analyzed by HPLC-UV-MS. The total ion chromatogram (TIC) of mixed standards was in good agreement with the HPLC-UV chromatogram ([Figure 2](#molecules-17-05836-f002){ref-type="fig"}). The majority of reference compounds were well-separated in 50 min. Pseudo-ginsenoside F~11~, an ocotillol type triterpene, lacked suitable chromophore and showed very poor UV absorption, so its corresponding peak was hardly detected at 203 nm ([Figure 2](#molecules-17-05836-f002){ref-type="fig"}A). However, it was readily detected using mass spectrometry, a universal, non-specific detector ([Figure 2](#molecules-17-05836-f002){ref-type="fig"}B).

![HPLC chromatograms of the mixed standards containing 21 saponins detected by (**A**) UV and (**B**) MS. D-Rb1, Didehydro-ginsenoside Rb~1~.](molecules-17-05836-g002){#molecules-17-05836-f002}

Although several pairs of saponins, including ginsenoside Rg~1~ and Re, ginsenoside Rf and notoginsenoside R~4~, chikusetsusaponin L~5~ and notoginsenoside Fa, notoginsenoside R~2~ and didehydro- ginsenoside Rb~1~, and ginsenoside Ra~3~ and Rb~1~, have identical retention times ([Figure 2](#molecules-17-05836-f002){ref-type="fig"}A), simultaneous determination could be accomplished by reference to the different MS of their molecular ions. For example, ginsenosides Rg~1~ and Re were co-eluted at the retention time of 13.5 min and failed to be distinguished with the UV detector ([Figure 2](#molecules-17-05836-f002){ref-type="fig"}A), but they were easily discriminated using extracted ion chromatograms (EIC) of their deprotonated molecular ions at *m/z* 799 and *m/z* 945, respectively ([Figure 3](#molecules-17-05836-f003){ref-type="fig"}A).

![Mass spectra of ginsenoside Rg~1~ and Re in negative mode. (**A**) EIC of *m/z* 945 and 799; (**B**) HPLC-ESI-MS spectra; (**C**) the CID spectra of adduct ion \[M+Cl\]^−^ of ginsenoside Re at *m/z* 981; (**D**) the CID spectra of parent ion \[M−H\]^−^ of ginsenoside Re at *m/z* 945 (The deprotonated ion is indicated by a vertical arrow).](molecules-17-05836-g003){#molecules-17-05836-f003}

In the negative ion mass spectra, the ionization of ginsenosides afforded intense deprotonated molecular ions \[M−H\]^−^ together with their corresponding adduct ions \[M+Cl\]^−^, instead of the expected \[M+AcO\]^−^ ion. In general, the generation of adduct ions depends on the mobile phase modifier \[[@B17-molecules-17-05836]\]. However, since chlorine-containing solvents were not employed during the whole HPLC-MS analysis, the presence of adduct ions \[M+Cl\]^−^ was considered to be generated from contamination of the ion source \[[@B25-molecules-17-05836],[@B26-molecules-17-05836]\]. In the ESI-MS spectra of ginsenoside Rg~1~ and Re, their deprotonated molecular ions \[M−H\]^−^ (*m/z* 799 and 945, respectively) and adduct ions \[M+Cl\]^−^ (*m/z* 835 and 981, respectively) were observed with high abundance ([Figure 3](#molecules-17-05836-f003){ref-type="fig"}B). However, in the CID spectrum of the adduct ion at *m/z* 981 ([Figure 3](#molecules-17-05836-f003){ref-type="fig"}C) and *m/z* 835 (not shown), the \[M−H\]^−^ ions were produced from \[M+Cl\]^−^ ions corresponding to loss of one HCl unit, which could helped to confirm the quasi-molecular ions.

The negative MS/MS spectra were obtained by collision-induced dissociation (CID) from the deprotonated molecular ion \[M−H\]^−^ ions, and the mass spectra of product ion of \[M−H\]^−^ exhibited a fragmentation pattern corresponding to the successive loss of the glycosidic units till the formation of \[aglycon-H\]^−^ ions. In addition, according to the structural properties of saponins, 20(*S*)-protopanaxatriol- type saponins possessed an aglycon ion at *m/z* 475 which was visible for ginsenoside Rg~1~, Re, Rf, and Rg~2~, while 20(*S*)-protopanaxadiol-type saponins, including ginsenoside Rb~1~, Rc, Rb~2~, Rb~3~ and Rd, produced an aglycon ion at *m/z* 459. The amount and the type of sugar moieties were also determined from CID spectra in which a mass difference of 162 indicated the presence of a β-D-glucose, 132 the presence of a pentose \[α-L-arabinose (pyranose or furanose) or β-D-xylose\] and 146 the presence of an α-L-rhamnose.

In the CID spectra of ginsenoside Re, the parent ion at *m/z* 945 and six main fragment ions at *m/z* 799, 783, 765, 637, 619 and 475 were observed ([Figure 3](#molecules-17-05836-f003){ref-type="fig"}D). The mass differences between the parent ion and fragment ions *m/z* 799 and 783 were 146 and 162, which corresponded to loss of one rhamnose unit and one glucose unit, respectively. The simultaneous loss of two sugar units indicated the existence of two different terminal residues of the glycosidic moieties in its chemical structure. The fragment ions at *m/z* 637 corresponded to the loss of a disaccharide consisting of the one rhamnose and one glucose unit. The fragment ions *m/z* 765 and 619 were the daughter ions produced from *m/z* 945, corresponding to the loss of one or two sugar unit and one unit of H~2~O molecule. The fragment ion at *m/z* 475, corresponding to 20(*S*)-protopanaxatriol aglycon moiety, was the result of a subsequent loss of all linked glucose unit. Thus, the mass spectra of the selected ginsenoside was characterized by the observation of the two main types of fragment ions, the ions produced from the consecutive loss of saccharide unit and the ions resulting from loss of the H~2~O molecule. According to the information of ESI-MS and MS/MS, the saponins were easily identified by mass spectrometry.

However, the MS-based structural analysis faced difficulties in some cases. Ginsenoside Rc, Rb~2~ and Rb~3~, belonging to the (20*S*)-protopanaxadiol-type saponins, have the same molecular weight and fragment ions. In their parent ion CID spectrum ([Figure 4](#molecules-17-05836-f004){ref-type="fig"}), the four mass intervals of 162, 132, 162 and 162 were also observed, which indicated the presence of three glucose unit and one pentose unit. However, the pentose unit could be xylose, arabinose (pyranose) and arabinose (furanose), which are present in ginsenosides Rc, Rb~2~ and Rb~3~ respectively. These three isomers could be distinguished by their retention times, 31.5 min, 34.3 min and 35.0 min for ginsenoside Rc, Rb~2~ and Rb~3~ respectively, in the total ion chromatogram (TIC).

Therefore, according to the TIC (retention time), ESI-MS (molecular weight) and MS/MS (fragment ion) information, the chromatographic behaviors and MS spectral of standards were characterized, which were the basis for identifying the ingredients in different parts of *P. notoginseng*.

![The CID spectra of parent ion \[M−H\]^−^ with *m/z* 1077. The deprotonated ion is indicated by a vertical arrow. Pen = pentose \[arabinose or xylose\].](molecules-17-05836-g004){#molecules-17-05836-f004}

2.3. HPLC-UV-MS Analysis of Different Parts of *P. notoginseng*
---------------------------------------------------------------

[Figure 5](#molecules-17-05836-f005){ref-type="fig"} shows representative UV and TIC chromatograms of different parts of *P. notoginseng*, which were acquired in separate runs using mobile phases of water-acetonitrile and 8 mM aqueous ammonium acetate-acetonitrile, respectively. A total of 41 saponins were separated and identified within 50 min, their structures were tentatively identified by careful studies of MS and MS/MS spectra and by comparison with literature data. The peak identification of notoginsenoside R~1~ (5), ginsenoside Rg~1~ (7), Re (8), notoginsenoside R~4~ (13), ginsenoside Rf (14), chikusetsusaponin L~5~ (15), notoginsenoside Fa (16), notoginsenoside R~2~ (19), didehydroginsenoside Rb~1~ (21), ginsenoside Ra~3~ (24), Rb~1~ (25), Rg~2~ (26), Rh~1~ (27), Rc (28), Rb~2~ (30), Rb~3~ (31), F~1~ (34), Rd (35), notoginsenoside K (36) and ginsenoside Rg~3~ (41), were also confirmed by spiked injection of the authentic standards.

The molecular mass could be clearly identified in their ESI-MS, and the type of ginsenoside and its sugar moiety could be further obtained using MS/MS. Therefore, those saponins that could not be identified from their retention times, due to lack of their chemical standards, could also be identified by their MS/MS spectral characteristics and by comparison with literature data. The MS data of characteristic peaks for identification are summarized in [Table 1](#molecules-17-05836-t001){ref-type="table"}.

![Representative HPLC-UV and MS chromatograms of different parts of *P. notoginseng*. (**A**) underground parts, (**B**) seed, (**C**) stem, (**D**) leaf and (**E**) flower, of *P. notoginseng*. UV, detected at the 203 nm; TIC, detected in negative ionization mode.](molecules-17-05836-g005){#molecules-17-05836-f005}

Peaks 13, 16 and 24 exhibited molecular ions at *m/z* 1,239 \[M−H\]^--^ and 1,275 \[M+CI\]^--^ in the ESI-MS spectra of the underground parts of *P. notoginseng*. The retention times were 25.6 min, 27.3 min and 29.5 min, respectively, as shown in EIC of *m/z* 1,239 ([Figure 6](#molecules-17-05836-f006){ref-type="fig"}A). The mass differences between the parent ion and fragment ions indicated the existence of four glucose units and one xylose unit in their structures. In addition, the fragment ion at *m/z* 459 corresponding to the protopanaxadiol aglycon moiety was observed in the CIDs of their parent ions ([Figure 6](#molecules-17-05836-f006){ref-type="fig"}B). Hence, the three peaks were finally identified as notoginsenoside R~4~, ginsenoside Fa and Ra~3~, respectively, which was confirmed by spiking with their chemical standards.

molecules-17-05836-t001_Table 1

###### 

HPLC-ESI-MS and corresponding CID data of saponins in different parts of *P. notoginseng.*

  No   Peak identification                                     RT(min)   MS ( *m/z*)   CID( *m/z*)   UG                                                                                                                                                                                                                                 a    b    c    d    
  ---- ------------------------------------------------------- --------- ------------- ------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---- ---- ---- ---- ----
  1    Yesanchinoside H                                        7.2       1093          1129          961\[M−H-Xyl\]^−^, 931\[M−H-Glc\]^−^, 799\[M−H-Xyl-Glc\]^−^, 637\[M−H-Xyl-2Glc\]^−^, 475 \[M−H-Xyl-2Glc\]^−^                                                                                                                       \+   \-   \-   \-   \-
  2    Notoginsenoside R~3~/R~6~/N/ 20-O-glucoginsenoside Rf   8.4       961           997           799\[M−H-Glc\]^−^, 637\[M−H-2Glc\]^−^, 475\[M−H-3Glc\]^−^                                                                                                                                                                          \+   \-   \-   \-   \-
  3    Notoginsenoside R~3~/R~6~/N/ 20-O-glucoginsenoside Rf   10.6      961           997           799\[M−H-Glc\]^−^, 637\[M−H-2Glc\]^−^, 475\[M−H-3Glc\]^−^                                                                                                                                                                          \+   \-   \-   \-   \-
  4    Notoginsenoside R~3~/R~6~/N/ 20-O-glucoginsenoside Rf   11.2      961           997           799\[M−H-Glc\]^−^, 637\[M−H-2Glc\]^−^, 475\[M−H-3Glc\]^−^                                                                                                                                                                          \+   \-   \-   \-   \-
  5    Notoinsenoside R~1~                                     11.5      931           967           799\[M−H-Xyl\]^−^, 769\[M−H-Glc\]^−^, 751\[M−H-Glc-H~2~O\]^−^, 637\[M−H-Glc-Xyl\]^−^, 619\[M−H-Glc-Xyl-H~2~O\]^−^, 475\[M−H-Xyl-2Glc\]^−^                                                                                          \+   \+   \+   \+   \+
  6    Notoinsenoside R~1~ isomer                              12.6      931           967           799\[M−H-Xyl\]^−^, 769\[M−H-Glc\]^−^, 637\[M−H-Glc-Xyl\]^−^, 475\[M−H-Xyl-2Glc\]^−^                                                                                                                                                \+   \-   \-   \-   \-
  7    Ginsenoside Rg~1~                                       13.6      799           835           637\[M−H-Glc\]^−^, 619\[M−H-Glc-H~2~O\]^−^, 475\[M−H-2Glc\]^−^                                                                                                                                                                     \+   \+   \+   \+   \+
  8    Ginsenoside Re                                          13.6      945           981           799\[M−H-Rha\]^−^, 783\[M−H-Glc\]^−^, 765.6\[M−H-Glc-H~2~O\]^−^, 637\[M−H-Rha-Glc\]^−^, 619\[M−H-Rha-Glc-H~2~O\]^−^, 475\[M−H-Rha-2Glc\]^−^                                                                                        \+   \+   \+   \+   \+
  9    Notoginsenoside E                                       15.3      979           1015          817\[M−H-Glc\]^−^, 799\[M−H-Glc-H~2~O\]                                                                                                                                                                                            \+   \-   \-   \-   \-
  10   Notoginsenoside A                                       15.5      1123          1159          \-                                                                                                                                                                                                                                 \+   \-   \-   \-   \-
  11   Ginsenoside G                                           17.9      959           996           797\[M-Glc\], 635\[M-2Glc\]^−^, 473\[M-3Glc\]^−^                                                                                                                                                                                   \+   \-   \-   \-   \-
  12   Notoginsenoside R~3~/R~6~/N/ 20-O-Glucoginsenoside Rf   21.9      961           998           799\[M−H-Glc\]^−^, 637\[M−H-2Glc\]^−^, 619\[M−H-2Glc-H~2~O\]^−^, 475\[M−H-3Glc\]^−^                                                                                                                                                \+   \-   \-   \-   \-
  13   Notoginsenoside R~4~                                    26.0      1239          1276          1107\[M−H-pen\]^−^, 945\[M−H-xyl-Glc\]^−^, 783\[M−H-xyl-2Glc\]^−^, 621\[M−H-xyl-3Glc\], 459\[M−H-xyl-4Glc\]^−^                                                                                                                     \+   \-   \-   \-   \-
  14   Ginsenoside Rf                                          26.1      799           835           637\[M−H-Glc\]^−^, 619\[M−H-Glc-H~2~O\]^−^, 475\[M−H-2Glc\]^−^,                                                                                                                                                                    \+   \-   \+   \-   \-
  15   Chikusetsusaponin L~5~                                  27.2      901           937           769\[M−H-Xyl\]^−^, 637\[M−H-Xyl-Ara\]^−^, 475\[M−H-Xyl-Ara-Glc\]^−^                                                                                                                                                                \+   \-   \+   \+   \+
  16   Notoginsenoside Fa                                      27.3      1239          1275          1107\[M−H-Xyl\]^−^, 1089\[M−H-Xyl-H~2~O\]^−^, 945\[M−H-Xyl-Glc\]^−^, 783\[M−H-Xyl-2Glc\]^−^, 621\[M−H-Xyl-3Glc\]^−^, 459\[M−H-Xyl-4Glc\]^−^                                                                                        \+   \-   \+   \+   \+
  17   Notoinsenoside Q/S                                      27.7      1341          1377          1209\[M−H-Xyl\]^−^, 1192\[M−H-Xyl-H~2~O\]^−^, 1077\[M−H-2Pen\]^−^, 945\[M−H-3Pen\]^−^, 783\[M−H-3Pen-Glc\]^−^, 621\[M−H-3Pen-2Glc\]^−^, 459\[M−H-3Pen-3Glc\]^−^                                                                    \-   \-   \-   \-   \+
  18   Notoginsenoside I                                       27.7      1091          1127          929\[M−H-Glc\]^−^, 767\[M−H-2Glc\]^−^, 605\[M−H-3Glc\]^−^, 443\[M−H-3Glc\]^−^                                                                                                                                                      \+   \-   \-   \-   \-
  19   Notoinsenoside R~2~                                     28.0      769           705           637\[M−H-Xyl\]^−^, 619\[M−H-Xyl-H~2~O\]^−^, 475\[M−H-Xyl-Glc\]^−^                                                                                                                                                                  \+   \-   \-   \-   \-
  20   Ginsenoside Fc/Ra~1~/Ra~2~                              28.1      1209          1245          1077\[M−H-Xyl\]^−^, 1047\[M−H-Glc\]^−^, 1027\[M−H-Glc-H~2~O\]^−^, 945\[M−H-Xyl-arab\]^−^,915\[M−H-Xyl-Glc\]^−^, 897\[M−H-Xyl-Glc-H~2~O\]^−^, 783\[M−H-Xyl-arab-Glc\]^−^ 621\[M−H-Xyl-arab-2Glc\]^−^, 459\[M−H-Xyl-arab-3Glc\]^−^   \-   \-   \-   \-   \+
  21   Didehydroginsenoside Rb~1~                              28.2      1105          1141          943\[M−H-Glc\]^−^, 781\[M−H-2Glc\]^−^, 619\[M−H-3Glc\]^−^, 457\[M−H-4Glc\]^−^                                                                                                                                                      \+   \-   \-   \-   \-
  22   Ginsenoside Fc/Ra~1~/Ra~2~                              28.9      1209          1245          1077\[M−H-Xyl\]^−^, 1059\[M−H-Xyl-H~2~O\]^−^, 1047\[M−H-Glc\]^−^, 945\[M−H-Xyl-arab\]^−^,915\[M−H-Xyl-Glc\]^−^, 783\[M−H-Xyl-arab-Glc\]^−^, 621\[M−H-Xyl-arab-2Glc\]^−^, 459\[M−H-Xyl-arab-3Glc\]^−^                               \-   \-   \+   \+   \+
  23   Notoinsenoside Q/S                                      29.1      1341          1377          1209\[M−H-Xyl\]^−^, 1077\[M−H-2Pen\]^−^, 945\[M−H-3Pen\]^−^, 783\[M−H-3Pen-Glc\]^−^, 621\[M−H-3Pen-2Glc\]^−^, 459\[M−H-3Pen-3Glc\]^−^                                                                                              \-   \-   \-   \-   \+
  24   Ginsenoside Ra~3~                                       29.5      1239          1275          1107\[M−H-Xyl\]^−^, 1089\[M−H-Xyl-H~2~O\]^−^, 945\[M−H-Xyl-Glc\]^−^, 783\[M−H-Xyl-2Glc\]^−^, 621\[M−H-Xyl-3Glc\]^−^, 459\[M−H-Xyl-4Glc\]^−^                                                                                        \+   \-   \-   \-   \-
  25   Ginsenoside Rb~1~                                       29.6      1107          1143          945 \[M−H-Glc\]^−^, 783\[M−H-2Glc\]^−^, 621\[M−H-3Glc\]^−^, 459\[M−H-4Glc\]^−^                                                                                                                                                     \+   \+   \+   \+   \+
  26   Ginsenoside Rg~2~                                       30.2      783           819           637\[M−H-Rha\]^−^, 619\[M−H-Rha-H~2~O\]^−^, 475\[M−H-Rha-Glc\]^−^                                                                                                                                                                  \+   \+   \+   \-   \-
  27   Ginsenoside Rh~1~                                       30.9      637           673           475\[M−H-Glc\]^−^                                                                                                                                                                                                                  \+   \-   \-   \-   \-
  28   Ginsenoside Rc                                          31.5      1077          1113          945\[M−H-Araf\]^−^, 915\[M−H-Glc\]^−^, 783\[M−H-Araf-Glc\]^−^, 765\[M−H-Araf-Glc-H~2~O\]^−^, 621\[M−H-Araf-2Glc\]^−^, 603\[M−H-Araf-2Glc-H~2~O\]^−^, 459\[M−H-Araf-3Glc\]^−^                                                       \+   \+   \+   \+   \+
  29   Ginsenoside Fc/Ra~1~/Ra~2~                              31.6      1209          1245          1077\[M−H-Xyl\]^−^, 1047\[M−H-Glc\]^−^, 945\[M−H-2Xyl/(-Xyl-Ara)\]^−^, \|783\[M−H-(2Xyl-Glc)/(-Xyl-Ara-Glc)\]^−^                                                                                                                   \+   \-   \-   \-   \-
  30   Ginsenoside Rb~2~                                       34.3      1077          1113          945\[M−H-Xyl\]^−^, 915\[M−H-Glc\]^−^, 783\[M−H-Araf-Glc\]^−^, 765\[M−H-Xyl-Glc-H~2~O\]^−^, 621\[M−H-Xyl-2Glc\]^−^, 603\[M−H-Xyl-2Glc-H~2~O\]^−^, 459\[M−H-Xyl-3Glc\]^−^                                                            \+   \+   \+   \+   \+
  31   Ginsenoside Rb~3~                                       35.0      1077          1113          945\[M−H-Xyl\]^−^, 915\[M−H-Glc\]^−^, 783\[M−H-Araf-Glc\]^−^, 765\[M−H-Xyl-Glc-H~2~O\]^−^, 621\[M−H-Xyl-2Glc\]^−^, 603\[M−H-Xyl-2Glc-H~2~O\]^−^, 459\[M−H-Xyl-3Glc\]^−^                                                            \+   \+   \+   \+   \+
  32   Notoginsenoside L                                       35.5      1077          1113          945\[M−H-Xyl\]^−^, 915\[M−H-Glc\]^−^, 783\[M−H-Xyl-Glc\]^−^, 765\[M−H-Xyl-Glc-H~2~O\]^−^, 621\[M−H-Xyl-2Glc\]^−^, 603\[M−H-Xyl-2Glc-H~2~O\]^−^,459\[M−H-Xyl-3Glc\]^−^                                                              \+   \+   \+   \+   \+
  33   Didehydroginsenoside Rd                                 35.7      943           979           781\[M−H-Glc\]^−^, 619\[M−H-2Glc\]^−^, 457\[M−H-3Glc\]^−^                                                                                                                                                                          \+   \-   \-   \-   \-
  34   Ginsenoside F~1~                                        36.3      637           673           475\[M−H-Glc\]^−^                                                                                                                                                                                                                  \+   \-   \-   \-   \-
  35   Ginsenoside Rd                                          37.0      945           981           783\[M−H-Glc\]^−^, 765\[M−H-Glc-H~2~O\]^−^, 621\[M−H-2Glc\]^−^, 603\[M−H-2Glc-H~2~O\]^−^, 459\[M−H-3Glc\]^−^                                                                                                                       \+   \+   \+   \+   \+
  36   Notoginsenoside K                                       38.3      945           981           783\[M−H-Glc\]^−^, 775\[M−H-Glc-H~2~O\]^−^, 621\[M−H-2Glc\]^−^, 459\[M−H-3Glc\]^−^                                                                                                                                                 \+   \+   \+   \+   \+
  37   Notoginsenoside O/P                                     38.6      1047          1083          915\[M−H-Xyl\]^−^, 897\[M−H-Xyl-H~2~O\]^−^, 783\[M−H-2Xyl\]^−^, 621 \[M−H-2Xyl-Glc\]^−^,459\[M−H-2Xyl-2Glc\]^−^                                                                                                                    \-   \-   \-   \+   \+
  38   Gypenoside IX/Notoginsenoside Fe/isomer                 39.5      915           951           783\[M-pen\]^−^, 621\[M-pen-glc\]^−^, 459\[M-pen-2glc\]^−^                                                                                                                                                                         \+   \-   \-   \+   \+
  39   Gypenoside IX/ Notoginsenoside Fe/isomer                39.7      915           951           783\[M-pen\]^−^, 621\[M-pen-glc\]^−^, 459\[M-pen-2glc\]^−^                                                                                                                                                                         \+   \-   \+   \+   \+
  40   Ginsenoside F~2~                                        42.1      783           819           621\[M−H-Glc\]^−^, 603\[M−H-Glc-H~2~O\]^−^, 459\[M−H-2Glc\]^−^                                                                                                                                                                     \+   \-   \-   \-   \-
  41   Ginsenoside Rg~3~                                       44.1      783           819           a621\[M−H-Glc\]^−^, 603\[M−H-Glc-H~2~O\]^−^, 459\[M−H-2Glc\]^−^                                                                                                                                                                    \+   \-   \+   \+   \+

UG, underground parts of *P. notoginseng* (including rhizome, root and fibre root); a, Seed; b, Stem; c, Leaf; d, Flower. -, Not detected; +, Detected.

![The extracted ion chromatogram of *m/z* 1,239 (**A**) and the CID spectra of parent ion \[M−H\]^−^ with *m/z* 1,239 (**B**) The mass-charge ratio of mass-selected ion is indicated by a vertical arrow.](molecules-17-05836-g006){#molecules-17-05836-f006}

Four peaks were observed to have molecular ions at *m/z* 961 \[M−H\]^−^ and *m/z* 997 \[M+CI\]^−^ in the ESI-MS of the underground parts of *P. notoginseng*. Their retention times were 8.4 min (2), 10.6 min (3), 11.2 min (4) and 21.9 min (12), respectively. The fragment ion at *m/z* 475 corresponding to the 20(*S*)-protopanaxatriol aglycon moiety was visible in CID spectra. Hence, the four peaks were tentatively identified as notoginsenoside R~3~, R~6~, N or 20-*O*-glucoginsenoside Rf, which possess the same molecular weight of 962 and belong to the 20(*S*)-protopanaxatriol type saponins \[[@B27-molecules-17-05836],[@B28-molecules-17-05836]\]. Similarly, peaks 17 and 23 were identified as notoginsenoside Q or S in the leaf and flower of *P. notoginseng*, which were isomers with molecular weight of 1,342 and belonged to 20(*S*)-protopanaxadiol type saponins \[[@B28-molecules-17-05836]\].

The pseudoginsenoside F~11~, an ocotillol-type saponin isolated from *P. quinquefolius*, was not detected in any part of *P. notoginseng*. Thus, pseudoginsenoside F~11~ could be a marker to distinguish *P. quinquefolius* from *Panax* genus plants \[[@B11-molecules-17-05836]\]. Liu *et al* reported that the malonylginsenosides Rb~1~, Rd and Rg1 were identified in the root of *P. notoginseng* using HPLC-ESI-MS \[[@B29-molecules-17-05836]\]. In this study, no malonylginsenoside was detected. The discrepancy between Liu's report and our study may be caused by the low contents of these compounds and their thermally sensitive degradation in the PLE extraction utilized in the present study. Several minor saponins were detected in the underground parts and tentatively identified as yesanchinoside H (1), notoginsenosides E (10), A (11), G (13), I (22), L (36) and didehydroginsenoside Rd (33), by comparing their MS spectra with literature data \[[@B27-molecules-17-05836],[@B28-molecules-17-05836],[@B30-molecules-17-05836],[@B31-molecules-17-05836],[@B32-molecules-17-05836]\].

The results showed that identical chemical ingredients presented in the underground parts of *P. notoginseng*, including root, fibre root and rhizome. However, the saponins were obviously different among the underground parts, seed, stem, leaf and flower. In total 36 peaks were identified in the underground parts of *P. notoginseng* (root, fibre root and rhizome), while 11, 17, 18 and 20 saponins were identified in the seed, stem, leaf and flower, respectively. Furthermore, the components of peaks 1--4, 6, 9--13, 18--19, 21, 24, 27, 29, 33, 34 and 40 were unique to the underground parts, notoinsenoside Q/S, ginsenoside Fc/Ra1/Ra2 were only found in flowers, and the notoginsenoside O/P were specifically contained in the leafs and flowers.

3. Experimental
===============

3.1. Chemicals, Standards and Samples
-------------------------------------

The samples of different parts from *P. notoginseng*, including rhizome, root, fibre root, seed, stem, leaf and flower, were derived from same batch of plants, obtained from Wenshan region, Yunnan Province, China. The peeled seed was used in this study. The botanical origins of materials were identified by Dr. Xiu-Ming Cui, Wenshan Prefecture Sanqi Research Institute, Yunnan Province. The voucher specimens were deposited at the Institute of Chinese Medical Sciences, University of Macau, Macao, China.

Notoginsenoside R~1~ was supplied by the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China); pseudo-ginsenoside F11, ginsenosides Rg~1~, Re, Rf, Rb~1~, Rg~2~, Rh~1~, Rc, Rb~2~, Rb~3~, Rd and Rg~3~ were purchased from International Laboratory (South San Francisco, CA, USA); Chikusetsusaponin L~5~, ginsenoside R~2~, F~1~, Ra~3~, notoginsenoside K, R~4~, Fa and didehydroginsenoside Rb~1~ were previously isolated and purified from the root of *P. notoginseng* by repeated silica gel, medium pressure liquid chromatography (MPLC) and preparative high performance liquid chromatography (prep-HPLC). Their structures were elucidated by comparison of their spectral data (MS, ^1^H-NMR and ^13^C-NMR) with corresponding references ([Figure 1](#molecules-17-05836-f001){ref-type="fig"}). Didehydroginsenoside Rb~1~ was a novel triterpene saponin we isolated from *P. notoginseng*, and its chemical structure was previously reported \[[@B32-molecules-17-05836]\]. Their purities were determined to be higher than 97% by normalization of the peak areas detected by HPLC-UV. HPLC-grade methanol and acetonitrile were products of Merck (Darmstadt, Germany), and the deionized water was purified by a Milli-Q purification system (Millipore, Bedford, MA, USA). Ammonium acetate was purchased from Riedel-de Haën (Seelze, Germany).

3.2. Pressurized Liquid Extraction
----------------------------------

Sample preparation was performed with a pressurized liquid extraction (PLE), which was operated on a Dionex ASE 200 system (Dionex Corp., Sunnyvale, CA, USA) under optimized conditions reported before \[[@B33-molecules-17-05836]\]. In brief, dried sample powder (0.5 g) was placed in an 11 mL stainless steel extraction cell. The optimized conditions were: particle size, 0.3--0.45 mm; solvent, methanol; temperature, 150 °C; static time, 15 min; pressure, 6.895 × 10^3^ MPa; static cycles, 1, and number of extractions, 1. PLE extract was transferred into a 25 mL volumetric flask which was brought up to its volume with the same solvent and filtered through a 0.45 μm Econofilter (Agilent Technologies, Palo Alto, CA, USA) prior to injection into the HPLC system.

3.3. HPLC-UV Analysis {#sec3dot3-molecules-17-05836}
---------------------

An Agilent 1100 series HPLC apparatus (Agilent Technologies), equipped with a vacuum degasser, quaternary gradient pump, autosampler and DAD detector, was used. A Zorbax SB-C18 column (250 mm × 4.6 mm, I.D., 5 μm) and a Zorbax SB-C18 guard column (12.5 mm × 4.6 mm I.D., 5 µm) were used. The mobile phase consisted of water (A) and acetonitrile (B) with the following gradient program: 0--3 min, 20--22% B; 3--25 min, 22--33% B; 25--30 min, remaining 33% B; 30--50 min, 33--70% B. The flow-rate was kept at 1.0 mL·min^−1^. The temperature was 25 °C. The detection wavelength was set at 203 nm and the sample injection volume was 10 µL.

3.4. HPLC-ESI-MS/MS Analysis
----------------------------

An LC-MSD trap VL mass spectrometer with electrospray ionization source (Agilent Technologies,) was coupled to the HPLC system described in [Section 3.3.](#sec3dot3-molecules-17-05836){ref-type="sec"} The chromatographic conditions for the HPLC-MS were the same as those used for the HPLC-UV, except that the water (A) of mobile phase was replaced by 8 mM aqueous ammonium acetate. The ESI-MS conditions were as follows: negative-ion mode; capillary voltage, 3.5 kV; dry gas N~2~, 12 L·min^−1^; temperature, 350 °C; pressure of nebulizer, 40 psi. The ESI-MS/MS was set with compounds stability of 100%, fragment amplification of 2.0 V and isolation width of 4. Scan range of both ESI-MS and ESI-MS/MS was fixed at *m/z* 200--1,400 U.

4. Conclusions
==============

In conclusion, an HPLC-ESI-MS/MS and PLE method was developed for the extraction and qualitative determination of saponins in different parts of *P. notoginseng*, including the rhizome, root, fiber root, seed, stem, leaf and flower. A total 41 saponins were identified and the chemical profiles of the different parts were obviously diverse. The developed HPLC-ESI-MS/MS method provided a reliable means of distinguishing the saponins in different parts of *P. notoginseng*, which should be helpful for the pharmacological evaluation and quality control of *P. notoginseng*.

We are grateful to Leon Lai from our institute for their expert technical assistances. The research was supported grants from Science and Technology Development Fund of Macau (the 049/2005/A-R1 to Y.T. Wang) and the Research Committee of the University of Macau (SRG009-ICMS12 to J.B. Wan).

*Sample Availability*: Samples of the compounds **5**, **7**, **8**, **13--16**, **19**, **21**, **24--28**, **30**, **31**, **34--36** and **41** are available from the authors.
